Bacteria
Qualification of a high-throughput luminescence-based Serum Bactericidal Activity assay to assess the functionality of human sera against five Shigella serotypes.
Boccadifuoco G, Fantoni G, Verdirosa F, Petri C, Lashchuk S, Mancini F, Piu P, Hogrefe W, Sunshine J, Micoli F, Rhyne PW, Alaimo C, Rossi O, Molesti E, Montomoli E, Manenti A. Vaccine. 2026 Aug 13;88:128965. doi: 10.1016/j.vaccine.2026.128965.
Current challenges and improvements in assessing the immunogenicity of bacterial vaccines.
Fantoni G, Boccadifuoco G, Verdirosa F, Molesti E, Manenti A, Montomoli E. Front Microbiol. 2024 Jul 9;15:1404637. doi: 10.3389/fmicb.2024.1404637. PMID: 39044946. PMCID: PMC11263209.
Characterization of Enzyme-Linked Immunosorbent Assay (ELISA) for Quantification of Antibodies against Salmonella Typhimurium and Salmonella Enteritidis O-Antigens in Human Sera.
Aruta MG, Lari E, De Simone D, Semplici B, Semplici C, Dale H, Chirwa E, Kadwala I, Mbewe M, Banda H, Iturriza-Gomara M, Gordon M, Nyirenda T, Piu P, Pizza M, Berlanda Scorza F, Grappi S, Canals R, Rossi O; On Behalf Of The Vacc-iNTS Consortium Collaborators. BioTech (Basel). 2023 Aug 11;12(3):54. doi: 10.3390/biotech12030054. PMID: 37606441.
Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development.
Piccini G, Montomoli E. Hum Vaccin Immunother. 2020 Sep 1;16(9):2056-2071. doi: 10.1080/21645515.2020.1785791. PMID: 32692622. PMCID: PMC7553687.
